Molecular Testing of Lung Cancers

Targeted therapies guided by molecular diagnostics have become a standard treatment of lung cancer. Epidermal growth factor receptor (EGFR) mutations and anaplastic lymphoma kinase (ALK) rearrangements are currently used as the best predictive biomarkers for EGFR tyrosine kinase inhibitors and ALK i...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Pathol Transl Med
Main Authors: Shim, Hyo Sup, Choi, Yoon-La, Kim, Lucia, Chang, Sunhee, Kim, Wan-Seop, Roh, Mee Sook, Kim, Tae-Jung, Ha, Seung Yeon, Chung, Jin-Haeng, Jang, Se Jin, Lee, Geon Kook
Formato: Artigo
Idioma:Inglês
Publicado em: The Korean Society of Pathologists and the Korean Society for Cytopathology 2017
Assuntos:
Review
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5445209/
https://ncbi.nlm.nih.gov/pubmed/28427247
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4132/jptm.2017.04.10
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados